Skip to main content
SpringerLink
Log in

Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

The cytotoxicity of mitotic spindle poisons, vinca alkaloids and the anthracycline, adriamycin, against cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cell lines was investigated. Interestingly, it was found that all cell lines were more sensitive to the mitotic spindle poisons, vincristine and vinblastine. Adriamycin was the least effective and taxol had intermediate activity. The Walker rat lymphoma cell line resistant to cisplatin (WR) exhibited the multiple drug resistance phenotype since it showed collateral resistance to all drugs (ranging from twofold to taxol, colcemid and colchicine and sixfold to the vinca alkaloids). Verapamil potentiated the cytotoxic activity of adriamycin and vincristine in a striking fashion with the Walker cells. P-glycoprotein was found to be present in the plasma membranes of the Walker cells with approximately a 2.5-fold increase in the WR as compared to the sensitive (WS) cells. Glutathione levels were elevated in all of the cisplatinresistant cell lines when compared to the cisplatin-sensitive parental cell lines. A profound effect of buthionine sulfoximine pretreatment on adriamycin cytotoxicity was observed. Glutathione S-transferase (π) was present in all the human cell lines but the WS cells had markedly lower levels (almost negligible) when compared to the WR cells. These observations imply that cisplatin-resistant cells may be more sensitive to mitotic spindle poisons and vinca alkaloids, irrespective of the mechanism of platinum resistance, and that the cytotoxicity of vinca alkaloids could be further modulated by verapamil, irrespective of the presence or absence of P-glycoprotein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andrews PA, Murphy MP, Howell SB (1985) Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45:6250

    PubMed  CAS  Google Scholar 

  2. Andrews PA, Schiefer MA, Murphy MP, Howell SB (1988) Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion. Chem-Biol Interact 65:51

    Article  PubMed  CAS  Google Scholar 

  3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248

    Article  PubMed  CAS  Google Scholar 

  4. Campling BG, Baer K, Baker HM, Lam Y-M, Cole SPC (1993) Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines? Br J Cancer 68:327

    PubMed  CAS  Google Scholar 

  5. Christen RD, Jekunen AP, Jones JA, Thiebaut F, Shalinsky DR, Howell SB (1993) In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. J Clin Invest 92:431

    Article  PubMed  CAS  Google Scholar 

  6. Chu G (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269:787

    PubMed  CAS  Google Scholar 

  7. Clapper ML, Kuzmich S, Seestaller LM, Tew KD (1993) Time course of glutathione S-transferase elevation in Walker mammary carcinoma cells following chlorambucil exposure. Biochem Pharmacol 45:683

    Article  PubMed  CAS  Google Scholar 

  8. Gately DP, Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin. A review. Br J Cancer 67:1171

    PubMed  CAS  Google Scholar 

  9. Godwin AK, Meister A, O’Dwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89:3070

    Article  PubMed  CAS  Google Scholar 

  10. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385

    Article  PubMed  CAS  Google Scholar 

  11. Hamaguchi K, Godwin AK, Yakushiji M, O’Dwyer PJ, Ozols RF, Hamilton TC (1993) Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 53:5225

    PubMed  CAS  Google Scholar 

  12. Hao X-Y, Bergh J, Brodin O, Hellman U, Mannervik B (1994) Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogenesis 15:1167

    Article  PubMed  CAS  Google Scholar 

  13. Harris AL, Hochhauser (1992) Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 31:205

    Article  PubMed  CAS  Google Scholar 

  14. Isonishi S, Andrews PA, Howell SB (1990) Increased sensitivity to cis-diamminedichloroplatinum (11) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoyl-phorbol 13-acetate. J Biol Chem 265:3623

    PubMed  CAS  Google Scholar 

  15. Jekunen AP, Shalinsky DR, Horn DK, Albright KD, Heath D, Howell SB (1993) Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 45:2079

    Article  PubMed  CAS  Google Scholar 

  16. Kawai K, Kamatani N, Georges E, Ling V (1990) Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum (II). J Biol Chem 265:13137

    PubMed  CAS  Google Scholar 

  17. Kelland LR (1994) The molecular basis of cisplatin sensitivity/resistance. Eur J Cancer 30A: 725

    Article  PubMed  CAS  Google Scholar 

  18. Kido Y, Khokhar AR, Siddik ZH (1994) Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells. Biochem Pharmacol 47:1635

    Article  PubMed  CAS  Google Scholar 

  19. Knox RJ, Lydall DA, Friedlos F, Basham C, Rawlings CJ, Roberts JJ (1991) The Walker 256 carcinoma:a cell type inherently sensitive to only those difunctional agents that can form DNA interstrand crosslinks. Mutat Res 255:227

    PubMed  CAS  Google Scholar 

  20. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680

    Article  PubMed  CAS  Google Scholar 

  21. Mann SC, Andrews PA, Howell SB (1991) Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-l-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 48:866

    Article  PubMed  CAS  Google Scholar 

  22. Mistry P, Loh S Y, Kelland LR, Harrap KR (1993) Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Int J Cancer 55:848

    Article  PubMed  CAS  Google Scholar 

  23. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55

    Article  Google Scholar 

  24. Nakagawa K, Yokota J, Wada M, Sasaki Y, Fujiwara Y, Sakai M, Muramatsu M, Terasaki T, Tsunokawa Y, Terada M, Saijo N (1988) Levels of glutathione S-transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn J Cancer Res 79:301

    PubMed  CAS  Google Scholar 

  25. Parekh H, Chitnis MP (1990) Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells. Selective Cancer Ther 6:93

    CAS  Google Scholar 

  26. Parekh HK, Chavan S, Chitnis MP (1991) Modulation of thiol pools by vitamin K3 and its effect on cell survival of sensitive and resistant murine tumor cells. Anticancer Drugs 2:159

    Article  PubMed  CAS  Google Scholar 

  27. Raderer M, Scheithauer W (1993) Clinical trials of agents that reverse multidrug resistance. Cancer 72:3553

    Article  PubMed  CAS  Google Scholar 

  28. Scanlon KJ, Kashani-Sabet M, Tone T, Funato T (1992) Cisplatin resistance in human cancers. Pharmacol Ther 52:385

    Article  Google Scholar 

  29. Sharma R, Singhal SS, Srivastava SK, Bajpai KK, Frenkel EP, Awasthi S (1993) Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. Cancer Lett 75: 111

    Article  PubMed  CAS  Google Scholar 

  30. Simpkins H, Lehman JM, Mazurkiewicz JE, Davis BH (1991) A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 51:1334

    PubMed  CAS  Google Scholar 

  31. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313

    PubMed  CAS  Google Scholar 

  32. Timmer-Bosscha H, Mulder NH, Vries EGF de (1992) Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br J Cancer 66:227

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Henry Simpkins

    Present address: Department of Pathology and Laboratory Medicine, Temple University School of Medicine, 3400 N. Broad Street, Room 106 Old Medical School, 19140, Philadelphia, PA, USA

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Temple University School of Medicine, 19140, Philadelphia, PA, USA

    Hemant Parekh

Authors
  1. Hemant Parekh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henry Simpkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parekh, H., Simpkins, H. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemother Pharmacol 37, 457–462 (1996). https://doi.org/10.1007/s002800050412

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002800050412

Key words

Search

Navigation